Clinical trial
Assessing Imaging as a Tool in Monitoring and Predicting the Progression of…
NCT00404170 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00404170 |
|---|---|
| Title | Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease |
| Official title | Assessing the Determinants of PD Progression - Long-term Dopamine Transporter Imaging in the PRECEPT Cohort |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | United States Department of Defense U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | B-CIT and SPECT imaging |
| Enrollment | 396 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Nov 27, 2006 |
| Last update posted | Jul 5, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: